en

PRODUCT DETAIL

Melphalan Zentiva 50 mg prášok a rozpúšťadlo na injekčný/infúzny roztok

Code 1690D
MA number 44/0177/19-S
Product Form: plv iio 1x50 mg+1x10 ml solv. (liek.inj.skl+liek.inj.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AA Nitrogen mustard analogues
L01AA03 Melphalan
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous and intraarterial use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 12.06.2019
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Melphalan Zentiva 50 mg_plv iio_03/2021.pdf  
PIL: PIL_Melphalan Zentiva 50 mg prášok a rozpúšťadlo na injekčný_infúzny roztok_11.2023.pdf  
Safety feature Yes
Data update: 08.11.2023
eu-flag.png sk-flag.png